Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about OPA1: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
OPA1 is a protein involved in neurodegeneration research. Key relationships include: activates, associated with, inhibits. Associated with ALS, Aging, Als. Connected to 309 entities in the SciDEX knowledge graph.
No AI portrait yet
| Gene Symbol | OPA1 |
| Full Name | Optic Atrophy 1 |
| Chromosome | 3q29 |
| Protein Type | Protein |
| Function | OPA1 is a nuclear-encoded mitochondrial protein that functions as a large GTPase mediating mitochondrial inner membrane fusion. |
| Subcellular Localization | the mitochondrial inner membrane where it mediates inner membrane fusion and maintains cristae structure. It is essentia |
| Molecular Weight | 120kDa |
| Amino Acids | 300 aa |
| Pathways | Apoptosis, Lysosomal Degradation, Mitochondrial Function, Mitophagy, Mtor |
| UniProt ID | O60313 |
| NCBI Gene ID | 4976 |
| GeneCards | OPA1 |
| Human Protein Atlas | OPA1 |
| Associated Diseases | aging, Als, Alzheimer, Cancer |
| Interactions | AGING, AKT, AKT1, ALZHEIMER, ALZHEIMER'S DISEASE, AMBRA1 |
| KG Connections | 785 knowledge graph edges |
| Databases | GeneCardsHPASTRING |
Knowledge base pages for this entity
graph TD
OPA1["OPA1"]
OPA1 -->|"activates"| Als["Als"]
OPA1 -->|"activates"| Cancer["Cancer"]
OPA1 -->|"regulates"| Ms["Ms"]
OPA1 -->|"expressed in"| Alzheimer["Alzheimer"]
OPA1 -->|"expressed in"| Dementia["Dementia"]
OPA1 -->|"activates"| Fibrosis["Fibrosis"]
OPA1 -->|"activates"| Ischemia["Ischemia"]
NRF1["NRF1"] -->|"activates"| OPA1
PPARGC1A["PPARGC1A"] -->|"target for"| OPA1
SIRT1["SIRT1"] -->|"target for"| OPA1
DNM1L["DNM1L"] -->|"target for"| OPA1
DRP1["DRP1"] -->|"activates"| OPA1
PRKAA1["PRKAA1"] -->|"target for"| OPA1
JUN["JUN"] -->|"target for"| OPA1
VDAC1["VDAC1"] -->|"activates"| OPA1
KRAS["KRAS"] -->|"activates"| OPA1| Target | Relation | Type | Str |
|---|---|---|---|
| Mitochondrial Dynamics | involved_in | process | 0.95 |
| Mitochondrial fusion | activates | process | 0.95 |
| Mitochondrial Fusion | involved_in | process | 0.90 |
| mitochondrial dynamics | participates_in | pathway | 0.90 |
| Mitochondrial Fusion | mediates | process | 0.88 |
| Mitochondrial Fusion | promotes | process | 0.85 |
| Alzheimer's Disease | biomarker_for | disease | 0.85 |
| Als | activates | disease | 0.85 |
| DRP1 | activates | gene | 0.80 |
| Als | expressed_in | disease | 0.75 |
| oxidative stress response | participates_in | pathway | 0.70 |
| MITOCHONDRIAL DYSFUNCTION | associated_with | gene | 0.70 |
| MITOCHONDRIA | activates | gene | 0.70 |
| Differentiation | activates | pathway | 0.70 |
| Mitochondrial Function | associated_with | pathway | 0.70 |
| hippocampus | expressed_in | brain_region | 0.70 |
| Apoptosis | implicated_in | pathway | 0.70 |
| Mitophagy | activates | pathway | 0.70 |
| Mtor | activates | pathway | 0.70 |
| Ischemia | therapeutic_target | disease | 0.65 |
| Atherosclerosis | regulates | disease | 0.65 |
| Tumor | regulates | disease | 0.65 |
| Cancer | causes | disease | 0.65 |
| Aging | activates | disease | 0.65 |
| Cardiac | regulates | disease | 0.65 |
| ALS | activates | disease | 0.65 |
| Cardiovascular | regulates | disease | 0.65 |
| Pyroptosis | causes | disease | 0.65 |
| Aging | causes | disease | 0.65 |
| Diabetes | expressed_in | disease | 0.65 |
| Neuroinflammation | expressed_in | disease | 0.65 |
| Cancer | activates | disease | 0.65 |
| Hypertension | regulates | disease | 0.65 |
| Ms | expressed_in | disease | 0.65 |
| Ischemia | regulates | disease | 0.65 |
| Cancer | expressed_in | disease | 0.65 |
| Cardiac | therapeutic_target | disease | 0.65 |
| Ms | therapeutic_target | disease | 0.65 |
| Neuropathy | associated_with | disease | 0.65 |
| Inflammation | regulates | disease | 0.65 |
| Alzheimer | inhibits | disease | 0.65 |
| Colorectal Cancer | activates | disease | 0.65 |
| Als | protects_against | disease | 0.65 |
| Parkinson | activates | disease | 0.65 |
| Inflammation | inhibits | disease | 0.65 |
| Neuroinflammation | inhibits | disease | 0.65 |
| Als | inhibits | disease | 0.65 |
| MITOCHONDRIAL DYSFUNCTION | causes | phenotype | 0.65 |
| Neurodegeneration | associated_with | disease | 0.65 |
| Als | regulates | disease | 0.65 |
| Source | Relation | Type | Str |
|---|---|---|---|
| Aging | downregulates | process | 0.85 |
| TAU | downregulates | protein | 0.85 |
| PM10 | downregulates | compound | 0.85 |
| Ros | cleaves | process | 0.85 |
| MFN2 | inhibits | gene | 0.80 |
| MITOPHAGY | activates | gene | 0.80 |
| AMPK | inhibits | gene | 0.70 |
| APOPTOSIS | implicated_in | gene | 0.70 |
| SIRT3 | activates | gene | 0.70 |
| ATP | inhibits | gene | 0.70 |
| Zn | activates | drug | 0.70 |
| MFN1 | inhibits | gene | 0.70 |
| Copper | inhibits | drug | 0.70 |
| CHCHD10 | regulates | gene | 0.65 |
| CHCHD10 | causes | gene | 0.65 |
| NEURONS | stabilizes | cell_type | 0.65 |
| NEURONS | destabilizes | cell_type | 0.65 |
| IFN | associated_with | gene | 0.60 |
| ATP | activates | gene | 0.60 |
| APOPTOSIS | activates | gene | 0.60 |
| PYROPTOSIS | causes | gene | 0.60 |
| MITOCHONDRIA | regulates | gene | 0.60 |
| APOPTOSIS | regulates | gene | 0.60 |
| IL-1 | causes | gene | 0.60 |
| MTDNA | causes | gene | 0.60 |
| DNA | causes | gene | 0.60 |
| CGAS-STING | causes | gene | 0.60 |
| IL-18 | activates | gene | 0.60 |
| IL-1 | activates | gene | 0.60 |
| CYTOKINES | activates | gene | 0.60 |
| BCL-2 | activates | gene | 0.60 |
| MAPK | activates | gene | 0.60 |
| DEMENTIA | therapeutic_target | gene | 0.60 |
| APOPTOSIS | therapeutic_target | gene | 0.60 |
| ROS | therapeutic_target | gene | 0.60 |
| APP/PS1 | therapeutic_target | gene | 0.60 |
| ATG | associated_with | gene | 0.60 |
| OXIDATIVE STRESS | implicated_in | gene | 0.60 |
| INFLAMMATION | regulates | gene | 0.60 |
| ROS | associated_with | gene | 0.60 |
| MAP1LC3 | associated_with | gene | 0.60 |
| GABARAPL1 | activates | gene | 0.60 |
| HSP60 | activates | gene | 0.60 |
| HSPD1 | activates | gene | 0.60 |
| HTRA2 | activates | gene | 0.60 |
| LAMP1 | activates | gene | 0.60 |
| NBR1 | activates | gene | 0.60 |
| NDP52 | activates | gene | 0.60 |
| AUTOPHAGY | associated_with | gene | 0.60 |
| AMPK | activates | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| OPA1-Mediated Cristae Architecture Vulnerability | 0.490 | neurodegeneration | What determines the specificity of TDP-4 |
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning OPA1 in their description or question text
No additional research found